Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (4 ops.)
Latest filing published 12 May 2017 for Aralez Pharmaceuticals Inc..
Filing timeline
BuySaleRobert Paul Harris
Insider track record
Disclosed buys
3
Disclosed sells
4
Signal history
Closed purchases
Market purchases
3
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert Paul Harris: trading record in brief
Robert Paul Harris is a declared insider at 2 companies; the most frequent names are Aralez Pharmaceuticals Inc. and Stellar Pharmaceuticals Inc. The record holds 11 filings, for trades running from 22 March 2012 to 11 May 2017.
Market trades split into 3 purchases (€657k) and 4 sales (€1.4M). Sales outweigh purchases by €699k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants and 2 option exercises.
A typical purchase (the median) is worth €233k.
The latest filing, published on 12 May 2017, reports a share grant in Aralez Pharmaceuticals Inc. The last purchase on record was published on 20 March 2013, which is 4,966 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert Paul Harris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
7,500 shares0Common Shares, without par valueSEC:0001104659-17-032409:0
20,000 shares@ US$3.924.1% of flowCommon Shares, without par valueSEC:0001104659-16-159835:0
20,000 shares@ US$4.654.8% of flowCommon Shares, without par valueSEC:0001104659-16-159835:1
104,778 shares@ US$3.9221.3% of flowCommon Shares, without par valueSEC:0001104659-16-159835:2
104,778 shares@ US$4.9927.1% of flowCommon Shares, without par valueSEC:0001104659-16-159835:3
75,000 shares@ US$5.6020.6% of flowCommon Shares, without par valueSEC:0001104659-16-145549:0
75,000 shares@ US$6.0422.2% of flowCommon Shares, without par valueSEC:0001104659-16-145549:1
7,500 shares0Common Shares, without par valueSEC:0001104659-16-128426:0
550,000 shares@ US$0.56Common SharesSEC:0001537250-13-000002:0
Canonical exit: 20 Jun 2012 (T+90)
625,000 shares@ US$0.40Common SharesSEC:0001537250-13-000002:2
Canonical exit: 28 May 2013 (T+90)
10 of 10 declarations
